We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $22.2B
1-Year Est. Return 58.34%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+58.34%
3 Year Est. Return
+153.02%
5 Year Est. Return
+199.78%
10 Year Est. Return
+811.75%
AUM
$22.2B
AUM Growth
+$2.96B
Cap. Flow
-$534M
Cap. Flow %
-2.4%
Top 10 Hldgs %
32.73%
Holding
727
New
37
Increased
291
Reduced
287
Closed
50

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$110M
2
ENTG icon
Entegris
ENTG
+$53.1M
3
HLT icon
Hilton Worldwide
HLT
+$45.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$44.3M
5
WDC icon
Western Digital
WDC
+$41.5M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$68.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.3M
3
MSFT icon
Microsoft
MSFT
+$64.1M
4
GILD icon
Gilead Sciences
GILD
+$63.1M
5
ON icon
ON Semiconductor
ON
+$62.5M

Sector Composition

Rank Sector Weight
1 Technology 38.31%
2 Healthcare 24.36%
3 Financials 9.42%
4 Communication Services 7.08%
5 Consumer Discretionary 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ULTA icon
176
Ulta Beauty
ULTA
$24.1B
$24.3M 0.11%
53,984
+9,529
+21% +$4.84M
ILMN icon
177
Illumina
ILMN
$33B
$24.3M 0.11%
138,268
+36,588
+36% +$5.36M
PEP icon
178
PepsiCo
PEP
$188B
$24.2M 0.11%
179,182
+26,752
+18% +$4M
TGT icon
179
Target
TGT
$74.7B
$24.2M 0.11%
185,717
+51,977
+39% +$6.6M
AMP icon
180
Ameriprise Financial
AMP
$49.5B
$24M 0.11%
52,473
-8,062
-13% -$3.7M
CRL icon
181
Charles River Laboratories
CRL
$13.8B
$23.8M 0.11%
105,152
+18,722
+22% +$3.33M
FTV icon
182
Fortive
FTV
$17.2B
$23.8M 0.11%
389,944
+62,586
+19% +$3.76M
SNOW icon
183
Snowflake
SNOW
$117B
$23.8M 0.11%
93,576
+32,377
+53% +$5.96M
ELV icon
184
Elevance Health
ELV
$88.4B
$23.5M 0.11%
60,901
+24,040
+65% +$8.92M
NTRA icon
185
Natera
NTRA
$47.3B
$23.2M 0.1%
85,677
– –
ANET icon
186
Arista Networks
ANET
$244B
$23.2M 0.1%
136,729
-711
-0.5% -$112K
MLYS icon
187
Mineralys Therapeutics
MLYS
$2.49B
$23.1M 0.1%
857,037
+55,133
+7% +$1.51M
MCD icon
188
McDonald's
MCD
$181B
$23.1M 0.1%
85,429
-7,904
-8% -$2.27M
PODD icon
189
Insulet
PODD
$10.2B
$23M 0.1%
151,100
+105,331
+230% +$17.5M
BBIO icon
190
BridgeBio Pharma
BBIO
$14.6B
$22.4M 0.1%
300,520
+21,632
+8% +$1.52M
KYMR icon
191
Kymera Therapeutics
KYMR
$9.76B
$22.1M 0.1%
192,880
-8,792
-4% -$755K
ORCL icon
192
Oracle
ORCL
$457B
$22M 0.1%
150,207
+5,924
+4% +$1.07M
MRNA icon
193
Moderna
MRNA
$58.1B
$21.6M 0.1%
309,196
+78,372
+34% +$4.05M
CBRE icon
194
CBRE Group
CBRE
$42.8B
$21.6M 0.1%
160,272
-7,498
-4% -$1.03M
FSLR icon
195
First Solar
FSLR
$22B
$21.4M 0.1%
90,923
-11,869
-12% -$2.78M
SNPS icon
196
Synopsys
SNPS
$75.5B
$21.3M 0.1%
47,900
-25,411
-35% -$11.9M
ALAB icon
197
Astera Labs
ALAB
$53.8B
$20.8M 0.09%
43,200
+7,458
+21% +$1.98M
MFC icon
198
Manulife Financial
MFC
$73.5B
$20.4M 0.09%
504,085
-66,522
-12% -$2.57M
RCUS icon
199
Arcus Biosciences
RCUS
$3.78B
$20.4M 0.09%
661,981
-128,632
-16% -$3.18M
PRAX icon
200
Praxis Precision Medicines
PRAX
$9.82B
$20.4M 0.09%
60,856
-2,772
-4% -$878K
6 7
8
9 10

Similar funds

DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $22.1B AUM 45.54% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $22.3B AUM 36.19% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $22.5B AUM 50.37% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Candriam SCA's Q2 2026 Portfolio in Review

As of Q2 2026, Candriam SCA held 727 positions worth $22.2B, up 15% from $19.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA's Q2 2026 filing shows 37 new, 291 increased, 287 reduced and 50 closed positions. Its largest new stake was BBVA Argentina: 1,335,000 shares worth $26.2M. The largest sale was Micron Technology, an estimated $68.2M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2026 buy was BBVA Argentina: 1,335,000 shares worth $26.2M.
  • Candriam SCA added most to Broadcom in Q2 2026, an estimated $110M increase.
  • Candriam SCA's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $68.2M.
  • Candriam SCA fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $52.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $22.2B portfolio in Q2 2026.
  • Candriam SCA opened 37 new positions and closed 50 in Q2 2026.
  • Candriam SCA's portfolio value rose 15% quarter-over-quarter to $22.2B.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.